Shunsuke Kimura1,2, Masafumi Seki1, Kenichi Yoshida3, Hiroo Ueno3, Yusuke Shiozawa3, Tomoya Isobe1, Kentaro Ohki4, Motohiro Kato4, Katsuyoshi Koh5, Ryoji Kobayashi6, Takao Deguchi7, Yoshiko Hashii8, Toshihiko Imamura9, Atsushi Sato10, Nobutaka Kiyokawa4, Atsushi Manabe11, Keizo Horibe12, Akira Ohara13, Masashi Sanada12, Masao Kobayashi2, Akira Oka1, Yasuhide Hayashi14, Satoru Miyano15, Seishi Ogawa3, Junko Takita1 (1.Department of Pediatrics, The University of Tokyo, Tokyo, Japan, 2.Department of Pediatrics, Hiroshima University, Hiroshima, Japan, 3.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4.Pediatric Hematology and Oncology Research, National Research Institute, Tokyo, Japan, 5.Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 6.Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan, 7.Department of Pediatrics, Mie University Hospital, Tsu, Japan, 8.Department of Pediatrics, Osaka University, Suita, Japan, 9.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 10.Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan, 11.Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan, 12.Clinical Research Center, National-Hospital Organization Nagoya Medical Center, Nagoya, Japan, 13.Department of Pediatrics, Toho University, Tokyo, Japan, 14.Gunma Children's Medical Center, Maebashi, Japan, 15.Human-Genome-Center Institute of Medical Science, The University of Tokyo)
Session information
Oral Session
Oral Session 3-5A ALL
Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.5 (Osaka International Convention Center, 12F Grand Toque)
Chair: Toshihiko Imamura (Dep. Pediatrics Kyoto Prefectural University of Medicine, Japan)
【E】
Takaomi Sanda1, Shi Hao Tan1, Wei Zhong Leong1, Phuong_Ct Ngoc1, Tze King Tan1, Fatima_C Bertulfo1, Mei Chee Lim2, Omer An1, Zhenhua Li3, Allen_Ej Yeoh3, Melissa_J Fullwood1, Daniel_G Tenen1 (1.Cancer Science Institute of Singapore, National University of Singapore, Singapore, Republic of Singapore, 2.Duke-National University of Singapore Graduate Medical School, Singapore, Republic of Singapore, 3.Department of Paediatrics, National University of Singapore, Singapore, Republic of Singapore)
Masanori Yoshida1,2,3, Kazuhiko Nakabayashi2,4, Hiroko Ogata4, Shin-Ichi Tsujimoto1,3, Tomoo Osumi1,2, Ryota Shirai1,2,3, Daisuke Tomizawa2, Nobutaka Kiyokawa1, Kenichiro Hata4, Motohiro Kato1,2 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Children's Cancer Center, NCCHD, Tokyo, Japan, 3.Department of Pediatrics, Yokohama City University, Yokohama, Kanagawa, 4.Maternal-Fetal Biology, NCCHD, Tokyo, Japan)
Satoshi Miyamoto1,4, Takuya Naruto1, Tomohiro Morio1,4, Kevin Urayama2,4, Atsushi Manabe3,4, Masatoshi Takagi1,4 (1.Department of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan, 2.Department of Social Medicine, NCCHD, Tokyo, Japan, 3.Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan, 4.Tokyo Children's Cancer Study Group (TCCSG))
Elias Jabbour1, Nicola Gokbuget2, Naohito Fujishima3, Anjali Advani4, Matthias Stelljes5, Wendy Stock6, Michaela Liedtke7, Giovanni Martinelli8, Susan OBrien9, Tao Wang10, A. Douglas Laird11, Erik Vandendries12, Alexander Neuhof13, Daniel J. DeAngelo14, Hagop Kantarjian1 (1.University of Texas, MD Anderson Cancer Center, Houston, United States of America, 2.Goethe University, Frankfurt, Federal Republic of Germany, 3.Akita University, Akita, Japan, 4.Cleveland Clinic Taussig Cancer Institute, Cleveland, United States of America, 5.Muenster University Hospital, Muenster, Federal Republic of Germany, 6.University of Chicago, Chicago, United States of America, 7.Stanford Cancer Institute, Stanford, United States of America, 8.Institute Seragnoli, University of Bologna, Bologna, Italian Republic, 9.University of California, Irvine Medical Center, Orange, United States of America, 10.Pfizer, Inc, Groton, United States of America, 11.Pfizer, Inc, San Diego, United States of America, 12.Pfizer, Inc, Cambridge, United States of America, 13.Pfizer Pharma GmbH, Berlin, Federal Republic of Germany, 14.Dana-Farber Cancer Institute, Boston, United States of America)
Lika'a F. Y. Al-Kzayer1, Yusuke Okuno2, Mazin F. Al-Jadiry3, Salma A. Al-Hadad3, Hussam S. Al-Abdullah4, Yozo Nakazawa1 (1.Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan, 2.Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine, Nagoya, Japan, 3.Department of Pediatrics, Children Welfare Teaching Hospital, Baghdad College of Medicine, Baghdad, Republic of Iraq, 4.Department of Pediatric Oncology, Basra Children Specialty Hospital, Basra, Republic of Iraq)